Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative ferric carboxymaltose versus placebo before elective coronary artery bypass grafting
2017-004901-41Phase 4Completed
- Sponsor
- Hospital District of Southwest Finland
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) and anaemia comparing Preoperative ferric carboxymaltose with Preoperative placebo (2 arms). Primary endpoint: Postoperative in-hospital nosocomial infections and/or blood transfusions. Started Apr 2018; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)anaemia
Beyond the preview
Go deeper on 2017-004901-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004901-41.